Literature DB >> 22819310

Optimization of chondrocyte isolation and characterization for large-scale cartilage tissue engineering.

Adelola O Oseni1, Peter E Butler, Alexander M Seifalian.   

Abstract

BACKGROUND: Advancements in cartilage tissue engineering have the potential to ameliorate facial and joint reconstructive surgery as we know it. The translation of in vitro models of cartilage regeneration into clinical scenarios is the next phase of cartilage tissue engineering research. To engineer larger, more robust, and clinical relevant constructs, a great number of viable chondrocytic cells are needed. However, there is a paucity of literature concerning the most favorable method of chondrocyte isolation. Isolation methods are inconsistent, resulting in small yields and poor cell quality, and thus unreliable neocartilage formation. This study aimed to optimize the chondrocyte isolation protocol to give a maximum yield with optimal cell viability for the engineering of large cartilaginous constructs such as the human nose and ear.
METHODS: We employed several enzymes (pronase, dispase, hyaluronidase, and collagenase), enzyme concentrations, and digest lengths to digest freshly harvested ovine nasoseptal cartilage. We used automated trypan blue live/dead staining, immunofluorescent labeling of CD44, collagenase II, collagenase I, and Aggrecan, and alamarBlue to assess cell yield and viability.
RESULTS: Incubation length in enzymatic solutions had the greatest effect on cell viability, whereas concentrations of enzymes had a lesser effect. Isolated cells maintained their expression of chondrocyte-specific cell surface markers.
CONCLUSIONS: The optimum incubation period was 10 h using collagenase at a 0.2% (w/v) solution. An average of 1-1.5 × 10(6) cells could be harvested per gram of cartilage using this method.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819310     DOI: 10.1016/j.jss.2012.05.087

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  30 in total

1.  Description of the immune microenvironment of chondrosarcoma and contribution to progression.

Authors:  François A Simard; Iseulys Richert; Alexandra Vandermoeten; Anne-Valérie Decouvelaere; Jean-Philippe Michot; Christophe Caux; Jean-Yves Blay; Aurélie Dutour
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

2.  Simple Silica Column-Based Method to Quantify Inorganic Polyphosphates in Cartilage and Other Tissues.

Authors:  Whitaik David Lee; Rahul Gawri; Toshikazu Shiba; Ae-Ri Ji; William L Stanford; Rita A Kandel
Journal:  Cartilage       Date:  2017-03-16       Impact factor: 4.634

3.  Beneficial effects of secretome derived from mesenchymal stem cells with stigmasterol to negate IL-1β-induced inflammation in-vitro using rat chondrocytes-OA management.

Authors:  Samuel Joshua Pragasam Sampath; Subha Narayan Rath; Nagasuryaprasad Kotikalapudi; Vijayalakshmi Venkatesan
Journal:  Inflammopharmacology       Date:  2021-09-21       Impact factor: 4.473

4.  In Vitro and Ectopic In Vivo Studies toward the Utilization of Rapidly Isolated Human Nasal Chondrocytes for Single-Stage Arthroscopic Cartilage Regeneration Therapy.

Authors:  Gyözö Lehoczky; Raluca Elena Trofin; Queralt Vallmajo-Martin; Shikha Chawla; Karoliina Pelttari; Marcus Mumme; Martin Haug; Christian Egloff; Marcel Jakob; Martin Ehrbar; Ivan Martin; Andrea Barbero
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

5.  Effect of short-term enzymatic treatment on cell migration and cartilage regeneration: in vitro organ culture of bovine articular cartilage.

Authors:  Dongrim Seol; Yin Yu; Hyeonghun Choe; Keewoong Jang; Marc J Brouillette; Hongjun Zheng; Tae-Hong Lim; Joseph A Buckwalter; James A Martin
Journal:  Tissue Eng Part A       Date:  2014-05-20       Impact factor: 3.845

6.  Effect of hyaluronidase on tissue-engineered human septal cartilage.

Authors:  Deborah Watson; Marsha S Reuther; Van W Wong; Robert L Sah; Koichi Masuda; Kristen K Briggs
Journal:  Laryngoscope       Date:  2016-06-13       Impact factor: 3.325

Review 7.  Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration?

Authors:  Damla Alkaya; Cansu Gurcan; Pelin Kilic; Acelya Yilmazer; Gunhan Gurman
Journal:  3 Biotech       Date:  2020-03-06       Impact factor: 2.406

8.  CircHYBID regulates hyaluronan metabolism in chondrocytes via hsa-miR-29b-3p/TGF-β1 axis.

Authors:  Hong-Xing Liao; Zhi-Hui Zhang; Hui-Lin Chen; Ying-Mei Huang; Zhan-Liang Liu; Jian Huang
Journal:  Mol Med       Date:  2021-05-31       Impact factor: 6.354

9.  Flightless I is a catabolic factor of chondrocytes that promotes hypertrophy and cartilage degeneration in osteoarthritis.

Authors:  Taku Ebata; Mohamad Alaa Terkawi; Masanari Hamasaki; Gen Matsumae; Tomohiro Onodera; Mahmoud Khamis Aly; Shunichi Yokota; Hend Alhasan; Tomohiro Shimizu; Daisuke Takahashi; Kentaro Homan; Ken Kadoya; Norimasa Iwasaki
Journal:  iScience       Date:  2021-05-24

10.  Optimization of Protocol for Isolation of Chondrocytes from Human Articular Cartilage.

Authors:  Suleiman Alhaji Muhammad; Norshariza Nordin; Paisal Hussin; Muhammad Zulfadli Mehat; Sheau Wei Tan; Sharida Fakurazi
Journal:  Cartilage       Date:  2019-09-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.